← All Companies
FutureTech II Acquisition Corp.
FTII · · SIC 2836: Biological Products, (No Diagnostic Substances)
Business Summary In this Report, references to the Company and to we, us and our refer to FutureTech II Acquisition Corp. Formation. We are a blank check company incorporated in Delaware on August 19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this annual report as our initial business combination (the Business Combination). A...
Next Earnings Q2 FY2026 — expected 2026-08-15
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention FTII discussed_in_filing Artificial Intelligence topic_mention FTII discussed_in_filing Cybersecurity topic_mention FTII discussed_in_filing Trusted Computing topic_mention FTII discussed_in_filing Blockchain & Crypto topic_mention FTII discussed_in_filing Robotics topic_mention FTII discussed_in_filing Regulation topic_mention FTII discussed_in_filing Enterprise topic_mention FTII discussed_in_filing Healthcare & Bio topic_mention FTII discussed_in_filing Sovereign & Government topic_mention FTII discussed_in_filing Artificial Intelligence topic_mention FTII discussed_in_filing Cybersecurity topic_mention FTII discussed_in_filing Trusted Computing topic_mention FTII discussed_in_filing Blockchain & Crypto topic_mention FTII discussed_in_filing Robotics topic_mention FTII discussed_in_filing Regulation topic_mention FTII discussed_in_filing Enterprise topic_mention FTII discussed_in_filing Healthcare & Bio topic_mention FTII discussed_in_filing Sovereign & Government topic_mention FTII discussed_in_filing Artificial Intelligence topic_mention FTII discussed_in_filing Cybersecurity
Annual Reports (10-K) Filed Period Accession Source Full Text 2025-04-09 2024-12-31 0001641172-25-003384 EDGAR 48K words 2024-04-05 2023-12-31 0001493152-24-013334 EDGAR — 2023-03-31 2022-12-31 0001493152-23-010345 EDGAR — 2022-03-31 2021-12-31 0001493152-22-008388 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-08-22 2025-06-30 0001641172-25-025250 EDGAR 32K words 2025-05-20 2025-03-31 0001641172-25-011790 EDGAR — 2025-01-28 2024-09-30 0001493152-25-004006 EDGAR — 2024-08-14 2024-06-30 0001493152-24-032073 EDGAR — 2024-05-16 2024-03-31 0001493152-24-020090 EDGAR — 2023-11-16 2023-09-30 0001493152-23-041663 EDGAR — 2023-08-14 2023-06-30 0001493152-23-028432 EDGAR — 2023-05-15 2023-03-31 0001493152-23-017290 EDGAR — 2022-11-14 2022-09-30 0001493152-22-032169 EDGAR — 2022-08-16 2022-06-30 0001493152-22-023057 EDGAR — 2022-05-16 2022-03-31 0001493152-22-013970 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-10 0001493152-26-009455 EDGAR 5K words 2026-02-19 0001493152-26-007470 EDGAR — 2026-01-16 0001493152-26-002585 EDGAR — 2025-11-12 0001493152-25-021600 EDGAR — 2025-08-18 0001641172-25-024668 EDGAR — 2025-08-18 0001641172-25-024504 EDGAR — 2025-08-12 0001641172-25-023249 EDGAR — 2025-04-11 0001641172-25-003707 EDGAR — 2025-03-28 0001641172-25-001125 EDGAR — 2025-02-21 0001493152-25-007856 EDGAR —
65 total filings indexed. 40 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001889450
Ticker FTII
Exchange —
SIC 2836: Biological Products, (No Diagnostic Substances)
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: d7e8a5314fa846d36eb46d6447c0b3a6abcb3ae3fa4a0e8a6f4dd85bed30d72e
parent: 9153051e9d4afd8ea2de5e94f5f4b641d8319aa1e694dc44f43393a36060ab5e
content hash: dd2268937d94321fd9e6b6256a36fc86f83524d2a29b01366c07045107640886
signed: 2026-04-13T04:45:09.524Z
sources: 15 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf